Achieving high-value chemical diversity for the pharmaceutical artificial intelligence

Insilico Medicine is adapting best neural network architectures. These advances are usually integrated into a comprehensive drug discovery pipeline with the goal to enable the deep neural networks to produce perfect molecules for the specific set of diseases. DruGAN allows the generation of new formulations for a wide range of diseases: different cancers, neurodegenerative diseases such as Alzheimer’s disease, virus infections, and more. …read more

Source: EurekAlert

(Visited 4 times, 1 visits today)

Popular Posts